IGI Logo

Margin holds; growth search continues

HDFC Life Insurance (HDFCLIFE IN) reported APE growth of 9% YoY to INR 35.2bn  individual APE growth remains at 7% YoY and continued to lag private industry growth of 15%. Q1FY27 witnessed strong shifts in product mix, even as the HDFC Bank channel stays subdued. Retail protection remains the standout, growing 42% YoY, while non-par savings and annuities recovered sharply and ULIP demand held up. VNB rose 8.7% YoY to INR 8.8bn, with VNB margin near stable at 25.0%, down 10bp YoY), management targets VNB margin to remain at current levels as it targets individual APE to grow in line with private companies. We recommend Buy with a target price of INR 740.

HDFC Bank recovery in sight; proprietary channels drive growth: Bancassurance remains soft in Q1, with a channel mix at 57% and business broadly flat YoY as HDFC Bank volume continues to be weak. However, management struck a markedly more constructive tone: it characterized the earlier weakness as a temporary bout of irrational competition and it chose to sit out, noting competition has currently normalized and HDFCLIFE's counter share has largely recovered to a year ago levels. With HDFC Bank still ~47% of retail APE, normalization is the key swing factor for FY27 growth. Meanwhile, proprietary channels did the heavy lifting agency grew 21% YoY (aided by branch expansion, with sub-24-month branches currently ~16% of agency APE), channels ex-HDFC Bank rose 17%, and proprietary channels together grew 20%+. This reinforces reduced single-distributor dependence; management reiterated an aspiration to grow at least in line with the industry, with VNB tracking APE.

Product mix turns; margin holds at ~25%: The mix shift was the quarter's real story. Non-par savings rebounded, with mix up ~220bp YoY to 18.6% (~22% of individual APE), as pricing competition eased and the rate & product backdrop improved; management flagged an exit run-rate near 25%. Annuities more than doubled YoY to ~9% of APE, led by variable annuity (AGNI), currently ~half of annuity sales at above-average margin. ULIP remains strong (mix 37.2%, up 450bp YoY) and retail protection extended its run, up 42% YoY (mix was up 160bp to 6.8%), although H2 growth should moderate on high base. The main drag was par, which nearly halved YoY off an elevated Q1FY26 base. VNB margin held at 25.0% with the residual GST drag was down to ~60bp and set to neutralize in the upcoming quarters; management remains growth-first, opting to reinvest mix-led margin upside rather than maximize it in the P&L. We build in ~11.8% APE CAGR and ~15.1% VNB CAGR during FY26-29E.

Recommend Buy with a TP of INR 740: We value the franchise on appraisal value approach; we recommend Buy with a TP of INR 740 based on 1.9x March 2028E EVPS of INR 386, implying ~30% upside to the CMP. We believe HDFCLIFE has faced increased competition in its non-par-guaranteed savings segment; as this intensity eases driven by HDFCLIFE improving the IRR for the products, we expect the product mix to become more favorable aiding in margin improvement, alongside growth converging towards industry levels. Further, we believe any material rationalization in first-year commissions by the IRDAI will pose a downside risk to our estimates.

Please refer disclaimer at Report
SEBI Registration number is INH000000933